5 Pharmaceutical preparations and substances for the treatment of, e.g., malignant tumor diseases and malignant and benign blood diseases, infectious diseases; diagnostic preparations and materials for medical purposes; diagnostic substances for medical use; diagnostic testing materials for medical use, namely, medical diagnostic test media in the form of, e.g., strips, threads, liquids, gels, serums, for measuring, e.g., biomarkers in malignant diseases and hereditary diseases on a genetic basis or protein basis, gene variants in hereditary diseases and malignant diseases; medical diagnostic test strips for e.g., blood analysis, urine analysis, saliva analysis; biotechnological preparations for medical use in the nature of, e.g., pharmaceutical preparations for the treatment of cancer, malignant and non-malignant blood diseases and hereditary diseases; medicine, namely, cytostatics, antibodies, antibody-drug conjugates, therapeutically modified lymphocytes, hormone preparations, preparations for the targeted treatment of malignant and non-malignant diseases; biopharmaceuticals for medical purposes in the nature of pharmaceutical preparations for the treatment of, e.g., malignant blood diseases, benign blood diseases, malignant solid tumors, benign solid tumors, cancer and hereditary diseases; biopharmaceuticals for medical purposes in the nature of pharmaceutical preparations for healing or alleviating ailments and reducing symptoms); biological preparations for medical purposes, namely, biological preparations for the treatment of, e.g., malignant blood diseases, benign blood diseases, malignant solid tumors, benign solid tumors; all the aforesaid goods relating to the fields of oncology, chemotherapy, molecular genetics, molecular medicine